| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical analysis of lung cancer in women
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 2 |
A clinical study on superior sulcus tumors
|
|
|
1995
|
13 |
2 |
p. 204-
1 p.
|
artikel
|
| 3 |
A comparative study between planar Ga-67, T1-201 images, chest x-ray, and x-ray CT in inoperable non-small cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 205-206
2 p.
|
artikel
|
| 4 |
Acquisitin and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences
|
|
|
1995
|
13 |
2 |
p. 193-194
2 p.
|
artikel
|
| 5 |
Adenoid cystic carcinoma of the tracheobronchial system: The role of postoperative radiotherapy
|
|
|
1995
|
13 |
2 |
p. 225-
1 p.
|
artikel
|
| 6 |
Adjuvant chemotherapy: Results and perspectives
|
|
|
1995
|
13 |
2 |
p. 220-
1 p.
|
artikel
|
| 7 |
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancer
|
|
|
1995
|
13 |
2 |
p. 189-190
2 p.
|
artikel
|
| 8 |
Air pollution and lung cancer in Trieste, Italy
|
|
|
1995
|
13 |
2 |
p. 187-
1 p.
|
artikel
|
| 9 |
Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb
|
|
|
1995
|
13 |
2 |
p. 196-
1 p.
|
artikel
|
| 10 |
Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cells
|
|
|
1995
|
13 |
2 |
p. 195-
1 p.
|
artikel
|
| 11 |
Analysis of the characteristics of human papilloma virus infection in 85 neoplasms of the respiratory system in adult patients
|
|
|
1995
|
13 |
2 |
p. 187-
1 p.
|
artikel
|
| 12 |
An immunoconjugate of Lys3-bombesin and monoclonal antibody 22 can specifically induce FcgammaRI (CD64)-dependent monocyte- and neutrophil-mediated lysis of small cell carcinoma of the lung cells
|
|
|
1995
|
13 |
2 |
p. 194-
1 p.
|
artikel
|
| 13 |
An 8 mm peripheral lung adenocarcinoma detected by routine sputum cytologic screening
|
|
|
1995
|
13 |
2 |
p. 210-
1 p.
|
artikel
|
| 14 |
Announcements
|
|
|
1995
|
13 |
2 |
p. 233-234
2 p.
|
artikel
|
| 15 |
An overview of prognostic factor in lung cancer
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 16 |
An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population
|
|
|
1995
|
13 |
2 |
p. 189-
1 p.
|
artikel
|
| 17 |
A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 222-223
2 p.
|
artikel
|
| 18 |
A phase II trial of combined chemotherapy and surgery in stage IIIA non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 228-
1 p.
|
artikel
|
| 19 |
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 214-215
2 p.
|
artikel
|
| 20 |
A pilot study of combination chemotherapy with cyclophosphamide, adriamycin, chronic daily dosing of oral etoposide for patients with SCLC ineligible for intensive chemotherapy
|
|
|
1995
|
13 |
2 |
p. 224-
1 p.
|
artikel
|
| 21 |
A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 216-217
2 p.
|
artikel
|
| 22 |
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 224-
1 p.
|
artikel
|
| 23 |
Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism
|
|
|
1995
|
13 |
2 |
p. 187-
1 p.
|
artikel
|
| 24 |
Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer
|
|
|
1995
|
13 |
2 |
p. 218-
1 p.
|
artikel
|
| 25 |
Atributable risk of lung cancer in lifetime nonsmokers and long-term ex-smokers (Missouri, United States)
|
|
|
1995
|
13 |
2 |
p. 186-
1 p.
|
artikel
|
| 26 |
Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 196-
1 p.
|
artikel
|
| 27 |
Biological prognostic factors in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 203-
1 p.
|
artikel
|
| 28 |
Biological response modifiers
|
|
|
1995
|
13 |
2 |
p. 218-
1 p.
|
artikel
|
| 29 |
Biologic and molecular prognostic factors-Impact on treatment of patients with non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 30 |
Bronchioloalveolar carcinoma
|
|
|
1995
|
13 |
2 |
p. 200-
1 p.
|
artikel
|
| 31 |
Bronchoalveolar lavage in the diagnosis of disseminated lung tumors
|
|
|
1995
|
13 |
2 |
p. 203-
1 p.
|
artikel
|
| 32 |
Bronchogenic carcinoma in 13 patients infected with the human immunodeficiency virus (HIV): Clinical and radiographic findings
|
|
|
1995
|
13 |
2 |
p. 206-
1 p.
|
artikel
|
| 33 |
Bronchoscopic findings of extramural lung cancer invading the subepithelium or submucosa
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 34 |
Camptothecin analogues in the treatment of non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 219-
1 p.
|
artikel
|
| 35 |
Carboplatin in treatment of patients with bronchogenic carcinoma
|
|
|
1995
|
13 |
2 |
p. 220-221
2 p.
|
artikel
|
| 36 |
Carcinoembryonic antigen in the diagnosis of lung cancer using bronchoalveolar lavage: A comparative study with healthy subjects, chronic bronchitis, respiratory infections and interstitial pulmonary diseases
|
|
|
1995
|
13 |
2 |
p. 204-
1 p.
|
artikel
|
| 37 |
Cardiac arrhythmia after lung cancer surgery — An analysis of 140 pneumonectomy cases
|
|
|
1995
|
13 |
2 |
p. 211-
1 p.
|
artikel
|
| 38 |
CEA, CYFRA21-1 and SCC in non-small cell lung cancer
|
Moro, D.
|
|
1995
|
13 |
2 |
p. 169-176
8 p.
|
artikel
|
| 39 |
Changes of surface antigens in drug-resistant human lung cancer cell lines and their susceptibility to LAK cells
|
|
|
1995
|
13 |
2 |
p. 223-
1 p.
|
artikel
|
| 40 |
Chemoprevention of lung cancer
|
|
|
1995
|
13 |
2 |
p. 185-
1 p.
|
artikel
|
| 41 |
Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian oncology group for clinical research (G.O.I.R.C.)
|
|
|
1995
|
13 |
2 |
p. 222-
1 p.
|
artikel
|
| 42 |
Chest X-ray screening improves outcome in lung cancer: A reappraisal of randomized trials on lung cancer screening
|
|
|
1995
|
13 |
2 |
p. 185-186
2 p.
|
artikel
|
| 43 |
Clinical study of adenosquamous carcinoma of the lung in 34 patients
|
|
|
1995
|
13 |
2 |
p. 210-
1 p.
|
artikel
|
| 44 |
Clinical tumour markers in lung cancer
|
|
|
1995
|
13 |
2 |
p. 211-
1 p.
|
artikel
|
| 45 |
Cognitive deficits in patients with small cell lung cancer before and after chemotherapy
|
|
|
1995
|
13 |
2 |
p. 215-
1 p.
|
artikel
|
| 46 |
Combination chemotherapy for unresectable lung cancer — Prevention of delay of courses and chemotherapy-induced neutropenia with administration of rhG-CSF
|
|
|
1995
|
13 |
2 |
p. 214-
1 p.
|
artikel
|
| 47 |
Combined endobronchial and conventional therapy of inoperable central lung cancer
|
|
|
1995
|
13 |
2 |
p. 231-
1 p.
|
artikel
|
| 48 |
Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 194-
1 p.
|
artikel
|
| 49 |
Concurrent chemoradiation for stage III non small cell lung cancer: Present results and future prospects
|
|
|
1995
|
13 |
2 |
p. 230-
1 p.
|
artikel
|
| 50 |
Concurrent chemoradiotherapy followed by surgery for advanced stage III non-small cell lung cancer (NSCLC)
|
|
|
1995
|
13 |
2 |
p. 229-
1 p.
|
artikel
|
| 51 |
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer: Results of radiation therapy oncology group 90-15
|
|
|
1995
|
13 |
2 |
p. 229-
1 p.
|
artikel
|
| 52 |
Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro
|
|
|
1995
|
13 |
2 |
p. 220-
1 p.
|
artikel
|
| 53 |
CT scanning of bronchioloalveolar carcinoma: Specific appearances
|
|
|
1995
|
13 |
2 |
p. 200-201
2 p.
|
artikel
|
| 54 |
Current status of retinoid chemoprevention of lung cancer
|
|
|
1995
|
13 |
2 |
p. 186-
1 p.
|
artikel
|
| 55 |
CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
|
|
|
1995
|
13 |
2 |
p. 207-
1 p.
|
artikel
|
| 56 |
CYP1A1 and CYP2E1 polymorphism and lung cancer, case-control study in Rio de Janeiro, Brazil
|
|
|
1995
|
13 |
2 |
p. 192-
1 p.
|
artikel
|
| 57 |
Cystic change (pseudocavitation) associated with bronchioloalveolar carcinoma: A report of four patients
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 58 |
Cytologic diagnosis of basal cell (basaloid) carcinoma of the lung: A report of two cases
|
|
|
1995
|
13 |
2 |
p. 193-
1 p.
|
artikel
|
| 59 |
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer: A useful outcome predictor
|
|
|
1995
|
13 |
2 |
p. 210-211
2 p.
|
artikel
|
| 60 |
Detecting recurrent or residual lung cancer with FDG-PET
|
|
|
1995
|
13 |
2 |
p. 204-
1 p.
|
artikel
|
| 61 |
Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 206-
1 p.
|
artikel
|
| 62 |
Distribution of GSTM1 null genotype in relation to gender, age and smoking status in Japanese lung cancer patients
|
|
|
1995
|
13 |
2 |
p. 187-
1 p.
|
artikel
|
| 63 |
Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung
|
|
|
1995
|
13 |
2 |
p. 198-
1 p.
|
artikel
|
| 64 |
Divergent differentiative histogenetic lines in lung tumors: Identification of histotypes with pure or mixed ultrastructural phenotype and their prognostic significance
|
|
|
1995
|
13 |
2 |
p. 199-
1 p.
|
artikel
|
| 65 |
Dose intensification — A phase I study of ifosfamide with vinorelbine (Navelbine): Rationale and study design in advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 221-
1 p.
|
artikel
|
| 66 |
Dose-intensive therapy for small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 215-
1 p.
|
artikel
|
| 67 |
Edatrexate studies in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 218-
1 p.
|
artikel
|
| 68 |
Effectiveness and toxicity of preoperative therapy in Stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2)
|
|
|
1995
|
13 |
2 |
p. 228-229
2 p.
|
artikel
|
| 69 |
Efficacy and toxicity of vinorelbine-carboplatin combination in the treatment of advanced adenocarcinoma or large-cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 215-216
2 p.
|
artikel
|
| 70 |
Environmental tobacco smoke: Science vs. rhetoric
|
|
|
1995
|
13 |
2 |
p. 186-
1 p.
|
artikel
|
| 71 |
Epidemiology of lung cancer: Recent trends in mortality with emphasis on Europe
|
|
|
1995
|
13 |
2 |
p. 188-
1 p.
|
artikel
|
| 72 |
Establishment and characterization of a new human lung poorly differenctiated adenocarcinoma cell line, GLL-1, producing carcinoemryonic antigen (CEA) and CA19-9
|
|
|
1995
|
13 |
2 |
p. 195-
1 p.
|
artikel
|
| 73 |
Etoposide (VP-16) and carboplatin as a first-line therapy in the small cell lung cancer (SCLC)
|
|
|
1995
|
13 |
2 |
p. 223-
1 p.
|
artikel
|
| 74 |
Evaluation of cases with combined bronchoplasty and pulmonary arterioplasty for the treatment of lung cancer
|
Wada, Hiromi
|
|
1995
|
13 |
2 |
p. 113-120
8 p.
|
artikel
|
| 75 |
Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin
|
|
|
1995
|
13 |
2 |
p. 217-
1 p.
|
artikel
|
| 76 |
Exercise capacity as a predictor of postoperative complications in lung resection candidates
|
|
|
1995
|
13 |
2 |
p. 212-213
2 p.
|
artikel
|
| 77 |
Existence of a well-defined pulmonary lesion on plain chest film predicts poor response of chemotherapy in small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 224-
1 p.
|
artikel
|
| 78 |
Expression of ras p21 and myc p64 oncoproteins in imprint smears of lung cancer
|
|
|
1995
|
13 |
2 |
p. 191-
1 p.
|
artikel
|
| 79 |
Ex-vivo fine needle aspiration. A new method of xenografting non-small cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 202-
1 p.
|
artikel
|
| 80 |
Factors causing radiation pneumonitis and the CT findings in lung cancer cases
|
|
|
1995
|
13 |
2 |
p. 227-
1 p.
|
artikel
|
| 81 |
Fatal pulmonary toxicity following oral etoposide therapy
|
|
|
1995
|
13 |
2 |
p. 223-
1 p.
|
artikel
|
| 82 |
18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 83 |
Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: Comparison with immunohistochemical results
|
|
|
1995
|
13 |
2 |
p. 199-
1 p.
|
artikel
|
| 84 |
Frequent loss of impringting of the H19 gene is often associated with its overexpression in human lung cancers
|
|
|
1995
|
13 |
2 |
p. 195-
1 p.
|
artikel
|
| 85 |
Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancels from japanese patients and its association with squamous cell carcinoma
|
|
|
1995
|
13 |
2 |
p. 190-
1 p.
|
artikel
|
| 86 |
Gemcitabine in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 219-
1 p.
|
artikel
|
| 87 |
Gender comparisons in human lung cancer: Analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression
|
|
|
1995
|
13 |
2 |
p. 190-
1 p.
|
artikel
|
| 88 |
Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility
|
|
|
1995
|
13 |
2 |
p. 216-
1 p.
|
artikel
|
| 89 |
Growth and biochemical effects of unsymmetrically substituted polyamine analogues in human lung tumor cells
|
|
|
1995
|
13 |
2 |
p. 195-
1 p.
|
artikel
|
| 90 |
Growth suppressive efficacy of human LAK cells against human lung cancer implanted into SCID mice
|
|
|
1995
|
13 |
2 |
p. 230-
1 p.
|
artikel
|
| 91 |
High-dose cisplatin with dipyridamole in advanced non-small cell lung cancer: A Grupo Oncologico Cooperativo del Sur study
|
|
|
1995
|
13 |
2 |
p. 221-
1 p.
|
artikel
|
| 92 |
High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 ( C57BL 6J x BALC cJ ) mice
|
|
|
1995
|
13 |
2 |
p. 190-
1 p.
|
artikel
|
| 93 |
High prevalence of bcl-2 oncoprotein expression in small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 198-
1 p.
|
artikel
|
| 94 |
HLA and tumor necrosis factor β gene polymorphisms in Okinawa lung cancer patients: Comparative study with mainland Japan lung cancer patients
|
|
|
1995
|
13 |
2 |
p. 191-
1 p.
|
artikel
|
| 95 |
Human lung carcinogen-DNA adduct levels mediated by genetic polymorhisms in vivo
|
|
|
1995
|
13 |
2 |
p. 191-192
2 p.
|
artikel
|
| 96 |
Hyperthermia in the treatment of brain metastases from lung cancer. Experience on 17 cases
|
|
|
1995
|
13 |
2 |
p. 231-
1 p.
|
artikel
|
| 97 |
IASLC calendar
|
|
|
1995
|
13 |
2 |
p. 181-183
3 p.
|
artikel
|
| 98 |
Immunohistochemical detectin of the laminin receptor polypeptide, a putative precursor of 67 kDa-laminin receptor, in human lung cancer
|
|
|
1995
|
13 |
2 |
p. 191-
1 p.
|
artikel
|
| 99 |
Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 197-198
2 p.
|
artikel
|
| 100 |
Immunohistochemical evaluatin of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 193-
1 p.
|
artikel
|
| 101 |
Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue
|
|
|
1995
|
13 |
2 |
p. 196-
1 p.
|
artikel
|
| 102 |
Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma
|
|
|
1995
|
13 |
2 |
p. 211-
1 p.
|
artikel
|
| 103 |
Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study
|
|
|
1995
|
13 |
2 |
p. 227-228
2 p.
|
artikel
|
| 104 |
Impact of chemotherapy on survival in locally advanced non-small cell lung cancer: The gustave-roussy experience
|
|
|
1995
|
13 |
2 |
p. 220-
1 p.
|
artikel
|
| 105 |
Increased radioresistance of an in vitro transformed human small cell lung cancer cell line
|
|
|
1995
|
13 |
2 |
p. 226-
1 p.
|
artikel
|
| 106 |
Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 230-231
2 p.
|
artikel
|
| 107 |
Induction of cytotoxic activity against lung adenocarcinoma by chimeric anti-Lewis Y antibody
|
|
|
1995
|
13 |
2 |
p. 231-
1 p.
|
artikel
|
| 108 |
Influences of cisplatin combination chemotherapy on oxygen radical generation by blood in elderly and adult patients with lung cancer
|
|
|
1995
|
13 |
2 |
p. 222-
1 p.
|
artikel
|
| 109 |
Initial experience of video assisted thoracoscopic pneumonectomy
|
|
|
1995
|
13 |
2 |
p. 213-
1 p.
|
artikel
|
| 110 |
Initial experience of video assisted thoracoscopic pneumonectomy
|
|
|
1995
|
13 |
2 |
p. 213-
1 p.
|
artikel
|
| 111 |
Initial report on the effectiveness of high dose rate brachytherapy in the treatment of hemoptysis in lung cancer
|
|
|
1995
|
13 |
2 |
p. 226-
1 p.
|
artikel
|
| 112 |
Interleukin-1α and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF
|
Gautier, Véronique
|
|
1995
|
13 |
2 |
p. 145-153
9 p.
|
artikel
|
| 113 |
Intranodal and extranodal tumour growth in early metastasised non-small cell lung cancer: Problems in histological diagnosis
|
|
|
1995
|
13 |
2 |
p. 200-
1 p.
|
artikel
|
| 114 |
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?
|
|
|
1995
|
13 |
2 |
p. 189-
1 p.
|
artikel
|
| 115 |
Is this patient fit for thoracotomy and resection of lung tissue?
|
|
|
1995
|
13 |
2 |
p. 202-
1 p.
|
artikel
|
| 116 |
Lobectomy — Video-assisted thoracic surgery versus muscle-sparing thoracotomy: A randomized trial
|
|
|
1995
|
13 |
2 |
p. 213-
1 p.
|
artikel
|
| 117 |
Long-term survival in small-cell lung cancer: Posttreatment characteristics in patients surviving 5 to 18+ years — An analysis of 1,714 consecutive patients
|
|
|
1995
|
13 |
2 |
p. 205-
1 p.
|
artikel
|
| 118 |
Lonidamine plus cyclophosphamide in the treatment of advanced non-small cell lung cancer in the elderly: A phase II study
|
|
|
1995
|
13 |
2 |
p. 218-
1 p.
|
artikel
|
| 119 |
Lung cancer
|
|
|
1995
|
13 |
2 |
p. 232-
1 p.
|
artikel
|
| 120 |
Lung cancer in radon-exposed miners and estimation of risk from indoor exposure
|
|
|
1995
|
13 |
2 |
p. 188-
1 p.
|
artikel
|
| 121 |
Lung perfusion and other methods of targeting therapy to lung tumors
|
|
|
1995
|
13 |
2 |
p. 223-224
2 p.
|
artikel
|
| 122 |
Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma
|
|
|
1995
|
13 |
2 |
p. 207-208
2 p.
|
artikel
|
| 123 |
Lung tumors derived from ectopic tissues
|
|
|
1995
|
13 |
2 |
p. 198-
1 p.
|
artikel
|
| 124 |
Lung tumors of uncertain histogenesis
|
|
|
1995
|
13 |
2 |
p. 198-
1 p.
|
artikel
|
| 125 |
Lymphoepithelioma-like carcinoma of the lung. Two cases diagnosed in Caucasian pateints
|
|
|
1995
|
13 |
2 |
p. 196-197
2 p.
|
artikel
|
| 126 |
Malignant mixed epithelial/mesenchymal neoplasmas of the lung
|
|
|
1995
|
13 |
2 |
p. 198-
1 p.
|
artikel
|
| 127 |
Malignant pleurisy and intrathoracic dissemination in carcinoma of the lung: Diagnostic, therapeutic and prognostic implications
|
|
|
1995
|
13 |
2 |
p. 203-
1 p.
|
artikel
|
| 128 |
Man-made vitreous fibers and risk of respiratory system cancer: A review of the epidemiologic evidence
|
|
|
1995
|
13 |
2 |
p. 187-
1 p.
|
artikel
|
| 129 |
Mediastinal lymph node dissection for lung cancer. The memorial experience
|
|
|
1995
|
13 |
2 |
p. 212-
1 p.
|
artikel
|
| 130 |
Mediastinal staging of lung cancer: The changing role of mediastinoscopy
|
|
|
1995
|
13 |
2 |
p. 205-
1 p.
|
artikel
|
| 131 |
Mentholated cigarette use and lung cancer
|
|
|
1995
|
13 |
2 |
p. 189-
1 p.
|
artikel
|
| 132 |
Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 219-
1 p.
|
artikel
|
| 133 |
Modifiers of exposure-response estimates for lung cancer among miners exposed to radon progeny
|
|
|
1995
|
13 |
2 |
p. 188-
1 p.
|
artikel
|
| 134 |
Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 204-205
2 p.
|
artikel
|
| 135 |
Molecular biologic features of non-small cell lung cancer. Clinical implications
|
|
|
1995
|
13 |
2 |
p. 232-
1 p.
|
artikel
|
| 136 |
Molecular markers in early cancer detection: New screening tools
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 137 |
Monitoring lung cancer with tissue polypeptide antigen: an ancillary, profitable serum test to evaluate treatment response and posttreatment disease status
|
Buccheri, Gianfranco
|
|
1995
|
13 |
2 |
p. 155-168
14 p.
|
artikel
|
| 138 |
Mortality from lung cancer and other diseases related to smoking among fishermen in north east Italy
|
|
|
1995
|
13 |
2 |
p. 189-
1 p.
|
artikel
|
| 139 |
Multimodality therapy in unresected stage III non-small cell lung cancer: The American Cooperative Groups' experience
|
|
|
1995
|
13 |
2 |
p. 228-
1 p.
|
artikel
|
| 140 |
Multiole forms of cathepsin B in human lung cancer
|
|
|
1995
|
13 |
2 |
p. 195-
1 p.
|
artikel
|
| 141 |
Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 203-
1 p.
|
artikel
|
| 142 |
N-acetylcysteine for lung cancer prevention
|
|
|
1995
|
13 |
2 |
p. 185-
1 p.
|
artikel
|
| 143 |
Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 228-
1 p.
|
artikel
|
| 144 |
New chemotherapeutic agents for non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 215-
1 p.
|
artikel
|
| 145 |
New drugs in non-small cell lung cancer. An overview
|
|
|
1995
|
13 |
2 |
p. 219-
1 p.
|
artikel
|
| 146 |
New therapeutic strategies involving radiation therapy for patients with non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 226-
1 p.
|
artikel
|
| 147 |
Non small cell lung cancer treatment with vinorelbine monochemotherapy: A phase II study
|
|
|
1995
|
13 |
2 |
p. 218-
1 p.
|
artikel
|
| 148 |
Observer variability in histopathological reporting of malignant bronchial biopsy specimens
|
|
|
1995
|
13 |
2 |
p. 200-
1 p.
|
artikel
|
| 149 |
On lung cancer in the patient in his eighties
|
|
|
1995
|
13 |
2 |
p. 213-214
2 p.
|
artikel
|
| 150 |
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy
|
|
|
1995
|
13 |
2 |
p. 204-
1 p.
|
artikel
|
| 151 |
Outcome of pneumonectomy for primary non-small cell lung cancer — A ten-year experience
|
|
|
1995
|
13 |
2 |
p. 212-
1 p.
|
artikel
|
| 152 |
p53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer
|
|
|
1995
|
13 |
2 |
p. 191-
1 p.
|
artikel
|
| 153 |
Paclitaxel (Taxol) and docetaxel (taxotere): Active chemotherapeutic agents in lung cancer
|
|
|
1995
|
13 |
2 |
p. 219-
1 p.
|
artikel
|
| 154 |
Palliative chemotherapy for non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 222-
1 p.
|
artikel
|
| 155 |
Palliative radiation for stage 3 non-small cell lung cancer — A prospective study of two moderately high dose regimens
|
Abratt, Raymond P.
|
|
1995
|
13 |
2 |
p. 137-143
7 p.
|
artikel
|
| 156 |
Palliative therapy: Extensive small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 232-
1 p.
|
artikel
|
| 157 |
Percutaneous pulmonary biopsy in the diagnosis of lung cancer
|
|
|
1995
|
13 |
2 |
p. 208-
1 p.
|
artikel
|
| 158 |
Perioperative chemotherapy and surgery for unresectable non-small cell lung cancer — A report of two cases
|
|
|
1995
|
13 |
2 |
p. 229-
1 p.
|
artikel
|
| 159 |
Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammine-glycolatoplatinum (254-S) and cis-diamminedichloroplatinum
|
|
|
1995
|
13 |
2 |
p. 217-
1 p.
|
artikel
|
| 160 |
Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 230-
1 p.
|
artikel
|
| 161 |
Phase I II study of carboplatin and oral etoposide with granulocyte- colony stimulating factor in advanced nonsmall cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 225-
1 p.
|
artikel
|
| 162 |
Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 229-230
2 p.
|
artikel
|
| 163 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: A hoosier oncology group trial
|
|
|
1995
|
13 |
2 |
p. 221-222
2 p.
|
artikel
|
| 164 |
Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 223-
1 p.
|
artikel
|
| 165 |
Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 215-
1 p.
|
artikel
|
| 166 |
Phase I study and clinical pharmacological evaluation of dairy oral etoposide combined with carboplatin in patients with lung cancer
|
|
|
1995
|
13 |
2 |
p. 216-
1 p.
|
artikel
|
| 167 |
Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 215-
1 p.
|
artikel
|
| 168 |
Pituitary and intradural spinal metastases: An unusual initial presentation of lung cancer
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 169 |
Policy against science: The case of environmental tobacco smoke
|
|
|
1995
|
13 |
2 |
p. 186-
1 p.
|
artikel
|
| 170 |
Postoperative interstitial pneumonia in primary lung cancer patients — Its causes and management
|
|
|
1995
|
13 |
2 |
p. 202-
1 p.
|
artikel
|
| 171 |
Prediction of survival time for patients with lung cancer and assessment of therapeutic effect
|
|
|
1995
|
13 |
2 |
p. 214-
1 p.
|
artikel
|
| 172 |
Presentation and dissent. The risk of lung cancer in nonsmokers in the united states and its reported association with environmental tobacco smoke
|
|
|
1995
|
13 |
2 |
p. 188-
1 p.
|
artikel
|
| 173 |
Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of veterans affairs cooperative study 188
|
|
|
1995
|
13 |
2 |
p. 216-
1 p.
|
artikel
|
| 174 |
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States
|
|
|
1995
|
13 |
2 |
p. 186-
1 p.
|
artikel
|
| 175 |
Primary lung cancer in young patients
|
|
|
1995
|
13 |
2 |
p. 204-
1 p.
|
artikel
|
| 176 |
Primary salivary gland-type tumors of the lung
|
|
|
1995
|
13 |
2 |
p. 198-199
2 p.
|
artikel
|
| 177 |
Processing of the neuropeptide growth factor antagonist [ARG6, D-TRP7,9, NmePHE8]-substance P (6–11) by a small cell lung cancer cell line (H69)
|
|
|
1995
|
13 |
2 |
p. 193-
1 p.
|
artikel
|
| 178 |
Prognosis and lung cancer: The contribution of plasma proteins
|
|
|
1995
|
13 |
2 |
p. 202-
1 p.
|
artikel
|
| 179 |
Prognostic factors in NSCLC. Recent experiences
|
|
|
1995
|
13 |
2 |
p. 203-
1 p.
|
artikel
|
| 180 |
Prognostic issues in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 181 |
Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioalveolar lung carcinoma
|
|
|
1995
|
13 |
2 |
p. 199-
1 p.
|
artikel
|
| 182 |
Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer
|
|
|
1995
|
13 |
2 |
p. 208-
1 p.
|
artikel
|
| 183 |
Radiologic evaluation in chest malignancies: A review of imaging modalities
|
|
|
1995
|
13 |
2 |
p. 201-
1 p.
|
artikel
|
| 184 |
Radiotherapeutic management of non-small cell lung cancer (NSCLC): An overview based on the clinical trials of the Radiation Therapy Oncology Group (RTOG)
|
|
|
1995
|
13 |
2 |
p. 226-227
2 p.
|
artikel
|
| 185 |
Radiotherapy in non-small cell lung cancer: Optimal doses and schedules
|
|
|
1995
|
13 |
2 |
p. 226-
1 p.
|
artikel
|
| 186 |
Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 228-
1 p.
|
artikel
|
| 187 |
Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: Results of a phase I–II study by the GOTHA group
|
|
|
1995
|
13 |
2 |
p. 230-
1 p.
|
artikel
|
| 188 |
Rapid reocclusion of left primary bronchus by fibrinomucinous cast in a case of large cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 189 |
Recent progress in chemotherapy for advanced lung cancer
|
|
|
1995
|
13 |
2 |
p. 223-
1 p.
|
artikel
|
| 190 |
Recent progress in chemotherapy for lung cancer
|
|
|
1995
|
13 |
2 |
p. 216-
1 p.
|
artikel
|
| 191 |
Relationship between response rate and median survival in patients with advanced non-small cell lung cancer: Comparison of ONCO-NASE(R) with other anticancer agents
|
|
|
1995
|
13 |
2 |
p. 225-
1 p.
|
artikel
|
| 192 |
Relationship of serum cholesterol, dietary and plasma β-carotene with lung cancer in male smokers
|
|
|
1995
|
13 |
2 |
p. 190-
1 p.
|
artikel
|
| 193 |
Resection of a superior sulcus tumor
|
|
|
1995
|
13 |
2 |
p. 212-
1 p.
|
artikel
|
| 194 |
Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance
|
|
|
1995
|
13 |
2 |
p. 217-218
2 p.
|
artikel
|
| 195 |
Risk of second cancers among lung cancer patients
|
|
|
1995
|
13 |
2 |
p. 208-
1 p.
|
artikel
|
| 196 |
Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
|
|
|
1995
|
13 |
2 |
p. 193-
1 p.
|
artikel
|
| 197 |
Second primary lung cancer
|
|
|
1995
|
13 |
2 |
p. 207-
1 p.
|
artikel
|
| 198 |
Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 208-
1 p.
|
artikel
|
| 199 |
Serum levels of interleukin 6 in patients with lung cancer
|
|
|
1995
|
13 |
2 |
p. 200-
1 p.
|
artikel
|
| 200 |
Serum tumour markers and management of non-small cell lung cancer
|
Splinter, T.A.W.
|
|
1995
|
13 |
2 |
p. 177-179
3 p.
|
artikel
|
| 201 |
Sigma receptors are expressed in human non-small cell lung carcinoma
|
|
|
1995
|
13 |
2 |
p. 192-193
2 p.
|
artikel
|
| 202 |
Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 227-
1 p.
|
artikel
|
| 203 |
Small adenocarcinoma of the lung: Histologic characterisitics and prognosis
|
|
|
1995
|
13 |
2 |
p. 197-
1 p.
|
artikel
|
| 204 |
Small cell lung cancer after chemotherapy. Morphological results
|
|
|
1995
|
13 |
2 |
p. 196-
1 p.
|
artikel
|
| 205 |
Small cell lung cancer: State-of-the-art therapy 1994
|
|
|
1995
|
13 |
2 |
p. 231-
1 p.
|
artikel
|
| 206 |
S-phase arrest of nutrient deprived lung cancer cells
|
|
|
1995
|
13 |
2 |
p. 194-
1 p.
|
artikel
|
| 207 |
Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 210-
1 p.
|
artikel
|
| 208 |
Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung
|
|
|
1995
|
13 |
2 |
p. 224-
1 p.
|
artikel
|
| 209 |
Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: Comparison between younger and older groups
|
|
|
1995
|
13 |
2 |
p. 207-
1 p.
|
artikel
|
| 210 |
Studies on the autologous tumor killing activity and lymphocyte subset in patients with lung cancer
|
|
|
1995
|
13 |
2 |
p. 192-
1 p.
|
artikel
|
| 211 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: A randomized trial by the Italian oncology group for clinical research
|
|
|
1995
|
13 |
2 |
p. 219-220
2 p.
|
artikel
|
| 212 |
Survival following radiotherapy for post-surgical locoregional recurrence of non-small cell lung cancer
|
Leung, J.
|
|
1995
|
13 |
2 |
p. 121-127
7 p.
|
artikel
|
| 213 |
Survival following resection of clinically occult N2 non small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 211-212
2 p.
|
artikel
|
| 214 |
Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients)
|
Wiatr, Elzbieta
|
|
1995
|
13 |
2 |
p. 129-135
7 p.
|
artikel
|
| 215 |
Telomerase activity in small-cell and non-small-cell lung cancers
|
|
|
1995
|
13 |
2 |
p. 192-
1 p.
|
artikel
|
| 216 |
The adenosquamous lung carcinoma: Clinicla and pathological characteristics
|
|
|
1995
|
13 |
2 |
p. 199-
1 p.
|
artikel
|
| 217 |
The combined treatment with surgery and chemotherapy: Primary approach to small cell lung carcinoma (SCLC)
|
|
|
1995
|
13 |
2 |
p. 227-
1 p.
|
artikel
|
| 218 |
The diagnostic accuracy of a solitary pulmonary nodule, using thin-section high resolution CT: A solitary pulmonary nodule by HRCT
|
Takanashi, Nobuko
|
|
1995
|
13 |
2 |
p. 105-112
8 p.
|
artikel
|
| 219 |
The effect of mitomycin-c, vinblastine, and cisplatin(MVP) combined chemotherapy in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 221-
1 p.
|
artikel
|
| 220 |
The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy
|
|
|
1995
|
13 |
2 |
p. 206-
1 p.
|
artikel
|
| 221 |
The management of lung cancer
|
|
|
1995
|
13 |
2 |
p. 231-232
2 p.
|
artikel
|
| 222 |
The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer
|
|
|
1995
|
13 |
2 |
p. 209-
1 p.
|
artikel
|
| 223 |
The plasminogen activation system and its role in lung cancer. A review
|
|
|
1995
|
13 |
2 |
p. 232-
1 p.
|
artikel
|
| 224 |
The possible role of autotransplantation in small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 221-
1 p.
|
artikel
|
| 225 |
Therapy of non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 231-
1 p.
|
artikel
|
| 226 |
The relationship between the immunodetection of transforming growth factor-β in lung adenocarcinoma and longer survival rates
|
|
|
1995
|
13 |
2 |
p. 210-
1 p.
|
artikel
|
| 227 |
The results of re-resection for lung cancer
|
|
|
1995
|
13 |
2 |
p. 212-
1 p.
|
artikel
|
| 228 |
The role of human chorionic gonadotropin β subunit elevation in small-cell lung cancer patients
|
|
|
1995
|
13 |
2 |
p. 200-
1 p.
|
artikel
|
| 229 |
The value of limited resection for ‘clinical’ stage I peripheral non-small cell lung cancer in poor-risk patients: Comparison of limited resection and lobectomy by a computer-assisted matched study
|
|
|
1995
|
13 |
2 |
p. 214-
1 p.
|
artikel
|
| 230 |
Thoracic and cranial radiotherapy for limited-stage small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 226-
1 p.
|
artikel
|
| 231 |
Thoracoscopy and video-assisted thoracic surgery in the treatment of lung cancer
|
|
|
1995
|
13 |
2 |
p. 211-
1 p.
|
artikel
|
| 232 |
Tracheal obstruction after placement of a metal wire expandable stent (Wallstent)
|
|
|
1995
|
13 |
2 |
p. 214-
1 p.
|
artikel
|
| 233 |
Transferrin receptor expression in nonsmall cell lung cancer: Histopathologic and clinical correlates
|
|
|
1995
|
13 |
2 |
p. 197-
1 p.
|
artikel
|
| 234 |
Trials with mitomycin, ifosfamide and cisplatin in non-small cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 217-
1 p.
|
artikel
|
| 235 |
Ultra-thin endoscopic findings of bronchioloalveolar carcinoma
|
|
|
1995
|
13 |
2 |
p. 210-
1 p.
|
artikel
|
| 236 |
Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
|
|
|
1995
|
13 |
2 |
p. 194-
1 p.
|
artikel
|
| 237 |
Videothoracoscopic staging and treatment of lung cancer
|
|
|
1995
|
13 |
2 |
p. 206-207
2 p.
|
artikel
|
| 238 |
Weekly vinorelbine in elderly patients with non-small-cell lung cancer
|
|
|
1995
|
13 |
2 |
p. 225-
1 p.
|
artikel
|
| 239 |
X-ray microanalysis of peripheral lung carcinoma
|
|
|
1995
|
13 |
2 |
p. 197-
1 p.
|
artikel
|
| 240 |
Zygomycosis orbital apex syndrome in association with a solitary lung carcinoma
|
|
|
1995
|
13 |
2 |
p. 202-
1 p.
|
artikel
|
Tijdschrift beschrijving